Mysteries of omicron variant could take weeks to untangleMysteries of omicron variant could take weeks to untangleMysteries of omicron variant could take weeks to untangle

Mysteries of omicron variant could take weeks to untangle

There are lots of guesses but little hard evidence as scientists race to find answers amid scrutiny from an anxious public.

from Section Page News - Modern Healthcare https://ift.tt/3G5jAU1

1st U.S. case of COVID omicron variant identified, Dr. Fauci says1st U.S. case of COVID omicron variant identified, Dr. Fauci says1st U.S. case of COVID omicron variant identified, Dr. Fauci says

1st U.S. case of COVID omicron variant identified, Dr. Fauci says

A person in California who had been vaccinated against COVID-19 became the first in the U.S. to have an identified case of the omicron variant, the White House announced.

from Section Page News - Modern Healthcare https://ift.tt/3oca1fR

New York City health systems say they're prepared for winter COVID upswing and omicron variantNew York City health systems say they're prepared for winter COVID upswing and omicron variantNew York City health systems say they're prepared for winter COVID upswing and omicron variant

New York City health systems say they're prepared for winter COVID upswing and omicron variant

Unlike during the first wave, New York City facilities now have enough supplies and beds.

from Section Page News - Modern Healthcare https://ift.tt/3D8z6MR

Telehealth may be here to stayTelehealth may be here to stayTelehealth may be here to stay

Telehealth may be here to stay

The use of remote health services soared during the pandemic.

from Section Page News - Modern Healthcare https://ift.tt/3DeA4Yb

Graphite Health taps Intermountain CIO as chief operating officerGraphite Health taps Intermountain CIO as chief operating officerGraphite Health taps Intermountain CIO as chief operating officer

Graphite Health taps Intermountain CIO as chief operating officer

Ryan Smith will continue to serve as Intermountain Healthcare's chief information officer through the first quarter of 2022.

from Section Page News - Modern Healthcare https://ift.tt/3xMBpV4

Biden tries to reassure on COVID as he sells spending planBiden tries to reassure on COVID as he sells spending planBiden tries to reassure on COVID as he sells spending plan

Biden tries to reassure on COVID as he sells spending plan

Biden has been eager to build momentum for his agenda, but he finds himself once again forced to divert attention to battling the virus.

from Section Page News - Modern Healthcare https://ift.tt/3dbpgiV

Indiana medical groups plead for more to get COVID-19 shotsIndiana medical groups plead for more to get COVID-19 shotsIndiana medical groups plead for more to get COVID-19 shots

Indiana medical groups plead for more to get COVID-19 shots

Indiana's top medical groups pleaded Tuesday for more people to get COVID-19 vaccine shots as the state is in the midst of a new surge of infections and hospitalizations.

from Section Page News - Modern Healthcare https://ift.tt/3xHlDdS

Omicron and other COVID variants: What you need to knowOmicron and other COVID variants: What you need to knowOmicron and other COVID variants: What you need to know

Omicron and other COVID variants: What you need to know

Here's what we know, and don't know, about the omicron variant.

from Section Page News - Modern Healthcare https://ift.tt/3rrIfOG

Massachusetts deploying COVID-19 antibody treatment unitsMassachusetts deploying COVID-19 antibody treatment unitsMassachusetts deploying COVID-19 antibody treatment units

Massachusetts deploying COVID-19 antibody treatment units

The clinics have the capacity to treat up to 500 patients per week with therapies that have can help reduce the severity of the disease and keep COVID-19-positive individuals from being hospitalized.

from Section Page News - Modern Healthcare https://ift.tt/3o959bs

U.S. panel backs first-of-a-kind COVID-19 pill from MerckU.S. panel backs first-of-a-kind COVID-19 pill from MerckU.S. panel backs first-of-a-kind COVID-19 pill from Merck

U.S. panel backs first-of-a-kind COVID-19 pill from Merck

The Food and Drug Administration panel voted 13-10 that the antiviral drug's benefits outweigh its risks, including potential birth defects if used during pregnancy.

from Section Page News - Modern Healthcare https://ift.tt/3ryIQxI